Clinical Trials Search at Vanderbilt-Ingram Cancer Center
Talazoparib + Enzalutamide vs. Enzalutamide Monotherapy in mCRPC
Prostate
Prostate
This study compares rPFS in men with mCRPC treated with talazoparib plus enzalutamide vs. enzalutamide after confirmation of the starting dose of talazoparib in combination with enzalutamide.
Prostate
III
Moses, Kelvin
NCT03395197
VICCURO17115